Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-25

Clinical Trial Update: Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of ridaforolimus with cetuximab in non-small cell lung cancer is terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)
  • Ridaforolimus (ridaforolimus)

Snippet

Sponsor: Angela Taber MD | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2015-06-25